Strategic Growth Target mid to small cap spine device manufacturers and distributors with complementary offerings to expand Kleiner Device Labs' reach, leveraging their patent portfolio and recognized KG2 Surge system to accelerate market penetration.

Healthcare Economics Position KG2 Surge and KG1 tools as cost-saving, safety-enhancing solutions that reduce operative time and potential complications, appealing to hospitals, healthcare systems, and insurers seeking efficiency and lower total cost of care.

Clinical Proof Emphasize proven performance claims and awards recognition to build credibility with procurement teams; leverage clinical testing data showing reduced fusion failure rates to support adoption in new facilities.

Strategic Partnerships Explore co-development or exclusive distribution agreements with surgical device distributors and venture-backed medical manufacturers to scale commercialization and access earlier-stage investment networks.

Market Expansion Leverage recent news and awards to generate targeted marketing campaigns in regions or institutions prioritizing minimally invasive spine solutions, while highlighting compatibility with open theater techniques to broaden adoption.